Search results
Jump to navigation
Jump to search
Page title matches
- ...[coronary heart disease]], [[cerebrovascular disorder]]s, and [[peripheral vascular disease]]. ...Godwin J et al.| title=Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised31 KB (4,198 words) - 11:24, 23 July 2015
- 279 bytes (37 words) - 17:50, 14 May 2010
- In [[medicine]], '''peripheral vascular disease''' is a "pathological processes involving any one of the blood vessels in t935 bytes (116 words) - 11:56, 15 February 2009
- Auto-populated based on [[Special:WhatLinksHere/Vascular disease]]. Needs checking by a human.2 KB (210 words) - 09:32, 8 March 2010
- 195 bytes (28 words) - 05:19, 6 September 2009
- 101 bytes (13 words) - 09:13, 7 January 2009
- Auto-populated based on [[Special:WhatLinksHere/Peripheral vascular disease]]. Needs checking by a human. {{r|Vascular disease}}495 bytes (64 words) - 19:27, 11 January 2010
Page text matches
- Auto-populated based on [[Special:WhatLinksHere/Vascular disease]]. Needs checking by a human.2 KB (210 words) - 09:32, 8 March 2010
- Auto-populated based on [[Special:WhatLinksHere/Peripheral vascular disease]]. Needs checking by a human. {{r|Vascular disease}}495 bytes (64 words) - 19:27, 11 January 2010
- ...esigned to test chemoprevention with aspirin for the primary prevention of vascular disease.185 bytes (23 words) - 04:30, 11 December 2011
- {{r|Peripheral vascular disease}} {{r|Vascular disease}}968 bytes (121 words) - 15:42, 11 January 2010
- ===Vascular disease=== NSAIDs, especially [[diclofenac]], may cause recurrence of [[vascular disease]] among patients with prior [[myocardial infarction]]s.<ref name="pmid21551 KB (134 words) - 06:45, 27 May 2011
- {{r|Vascular disease}}854 bytes (105 words) - 11:08, 11 January 2010
- ...or simply '''Syndrome X''', is a "cluster of metabolic risk factors for [[vascular disease|cardiovascular disease]]s and [[Diabetes mellitus type 2|type 2 diabetes me629 bytes (71 words) - 11:35, 17 April 2009
- {{r|Vascular disease}}504 bytes (64 words) - 10:56, 11 January 2010
- {{r|Vascular disease}}516 bytes (66 words) - 17:20, 11 January 2010
- {{r|Vascular disease}}634 bytes (80 words) - 17:15, 11 January 2010
- In [[medicine]], '''peripheral vascular disease''' is a "pathological processes involving any one of the blood vessels in t935 bytes (116 words) - 11:56, 15 February 2009
- {{r|Peripheral vascular disease}}592 bytes (76 words) - 19:27, 11 January 2010
- {{r|Vascular disease}}348 bytes (42 words) - 23:54, 26 January 2011
- {{r|Vascular disease}}796 bytes (99 words) - 10:52, 11 January 2010
- {{r|Vascular disease}}720 bytes (96 words) - 19:58, 11 January 2010
- {{r|Vascular disease}}403 bytes (39 words) - 15:00, 27 May 2010
- {{r|Vascular disease}}992 bytes (122 words) - 11:06, 11 January 2010
- ...t of [[hypertension]], vasospasm, [[peripheral arterial disease|peripheral vascular disease]], [[shock]], and [[pheochromocytoma]]."<ref>{{MeSH}}</ref> They are also u2 KB (288 words) - 11:04, 11 June 2010
- {{r|Vascular disease}}1 KB (187 words) - 20:40, 11 January 2010
- ===Prediction vascular disease and mortality===3 KB (418 words) - 13:21, 15 February 2009
- {{r|Vascular disease}}487 bytes (61 words) - 10:58, 11 January 2010
- {{r|Vascular disease}}515 bytes (67 words) - 18:28, 11 January 2010
- {{r|Vascular disease}}1 KB (153 words) - 17:20, 11 January 2010
- {{r|Peripheral vascular disease}}481 bytes (62 words) - 21:28, 11 January 2010
- {{r|Vascular disease}}591 bytes (74 words) - 16:33, 11 January 2010
- {{r|Vascular disease}}686 bytes (93 words) - 10:58, 11 January 2010
- ...Kaptoge S, Ray KK et al.| title=Major lipids, apolipoproteins, and risk of vascular disease. | journal=JAMA | year= 2009 | volume= 302 | issue= 18 | pages= 1993-2000 |2 KB (299 words) - 01:31, 21 September 2010
- ===Vascular disease=== {{main|Vascular disease}}5 KB (688 words) - 21:20, 2 September 2011
- {{r|Vascular disease}}812 bytes (102 words) - 19:58, 11 January 2010
- {{r|Vascular disease}}2 KB (310 words) - 12:22, 18 April 2024
- {{r|Vascular disease}}3 KB (366 words) - 12:22, 18 April 2024
- ...arge enough for the presence of hyperuricemia to help in the prediction of vascular disease.<ref name="pmid15783260">{{cite journal |author=Wheeler JG, Juzwishin KD, E6 KB (819 words) - 22:44, 13 July 2010
- ...[[chemoprevention]] with [[aspirin]] for the [[primary prevention]] of [[vascular disease]].<ref name="pmid3125882">{{cite journal| author=Peto R, Gray R, Collins R,2 KB (242 words) - 21:10, 22 August 2010
- ...supplementation may actually be harmful when used for the prevention of [[vascular disease]].<ref name="pmid15537682">{{cite journal |author=Miller ER, Pastor-Barri1 KB (193 words) - 03:28, 6 January 2011
- ...beta-synthase]] and is a risk factor for [[coronary heart disease|coronary vascular disease]]."<ref>{{MeSH|Hyperhomocysteinemia}}</ref><ref name="OMIM - Hyperhomocyste ...fman JS, ''et al'' |title=Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomize8 KB (1,016 words) - 10:28, 2 November 2009
- ===Vascular disease prevention=== ...005758 |issn=}}</ref> and [[vitamin E]] (α-tocopherol) and reductions in [[vascular disease]].<ref name="pmid8479463">{{cite journal |author=Stampfer MJ, Hennekens CH,9 KB (1,254 words) - 01:42, 23 May 2009
- ...Ib-IIIa complex and inhibit platelet aggregation. They arp used to treat [[vascular disease]]s.2 KB (291 words) - 21:55, 14 February 2010
- ...n to have numerous healthful benefits. It has been shown to reduce cardio-vascular disease3 KB (407 words) - 08:24, 28 October 2009
- Estrogen replacement therapy was at one time thought to reduce death from [[vascular disease]] due to the findings of the Nurse' Health Study.<ref name="pmid1870648">{{5 KB (693 words) - 22:47, 19 October 2011
- ...mmon cause of eosinophilia in the United States), malignancy, and collagen-vascular disease.3 KB (322 words) - 11:33, 6 August 2010
- ...h-risk diabetes|| "Telmisartan was equivalent to ramipril in patients with vascular disease or high-risk diabetes and was associated with less angioedema. The combinat15 KB (2,041 words) - 22:49, 6 June 2012
- Originally thought to reduce vascular disease<ref name="pmid1443971">American College of Physicians. 1992 http://pubmed.g7 KB (894 words) - 05:24, 10 September 2010
- ===Vascular disease=== NSAIDs, especially [[diclofenac]], may cause recurrence of [[vascular disease]] among patients with prior [[myocardial infarction]]s.<ref name="pmid2155514 KB (1,835 words) - 06:45, 27 May 2011
- ...ordestgaard BG |title=Genetically elevated C-reactive protein and ischemic vascular disease |journal=N. Engl. J. Med. |volume=359 |issue=18 |pages=1897–908 |year=20018 KB (2,514 words) - 01:24, 1 June 2012
- | journal =The British Journal of Diabetes and Vascular Disease4 KB (480 words) - 03:50, 26 April 2012
- ...psychological]] diseases, [[antiviral drug]]s, [[erectile dysfunction]], [[vascular disease]], [[steroid]]-related diseases, [[migraine headache]]s, [[sleep disorder]]8 KB (985 words) - 19:04, 4 September 2013
- ...psychological]] diseases, [[antiviral drug]]s, [[erectile dysfunction]], [[vascular disease]], [[steroid]]-related diseases, [[migraine headache]]s, [[sleep disorder]]8 KB (984 words) - 19:05, 4 September 2013
- ...[coronary heart disease]], [[cerebrovascular disorder]]s, and [[peripheral vascular disease]]. ...Godwin J et al.| title=Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised31 KB (4,198 words) - 11:24, 23 July 2015
- ...psychiatric illnesses, neoplasms, infections, posttraumatic sequelae, and vascular disease. Causes of dementia can be identified or eliminated by history and clinical11 KB (1,654 words) - 09:12, 31 August 2010
- ...supplementation may actually be harmful when used for the prevention of [[vascular disease]].<ref name="pmid15537682">{{cite journal |author=Miller ER, Pastor-Barriu13 KB (1,824 words) - 20:28, 25 June 2012
- ...f losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial. | journal=Ann Intern Med | year=4 KB (610 words) - 23:42, 24 May 2012
- ===Vascular disease prevention=== Vitamin D may help prevent [[vascular disease]].<ref name="pmid20194238">{{cite journal| author=Wang L, Manson JE, Song Y24 KB (3,504 words) - 10:09, 21 November 2013
- ...MHO subjects, whilst the same study also highlighted signs of sub-clinical vascular disease, which if left untreated could lead to consequences in later life (Janiszew16 KB (2,369 words) - 09:35, 1 December 2013
- ...holesterol and [[apolipoprotein]] B levels may better predict subsequent [[vascular disease]] thatn LDL-C levels.<ref name="pmid22453571">{{cite journal| author=Boekho ...s of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. | journal=Lanc42 KB (5,816 words) - 10:22, 8 March 2015
- ...ative explanation of the association of low bir thweight with diabetes and vascular disease. ''Lancet''353:1789-925 KB (669 words) - 08:49, 11 October 2010
- * Vascular disease9 KB (1,169 words) - 02:01, 29 October 2013
- ...disease''' (CHD), also called '''coronary artery disease''' (CAD), is a [[vascular disease]] caused by abnormalities the arteries that supply the heart with blood (ca : See also: [[Vascular disease#Prognosis]]41 KB (5,532 words) - 23:14, 6 October 2013
- ...(2000) [http://books.google.com/books?id=ARApFFQQibAC Oxidative Stress and Vascular Disease.] Springer:. ISBN 0792386787, ISBN 780792386780, 373 pages. ...s designed to appeal to both scientists and clinicians with an interest in vascular disease and its underlying pathophysiology.</ref>31 KB (4,638 words) - 18:09, 29 October 2017
- ===Pulmonary vascular disease===15 KB (2,125 words) - 17:43, 11 June 2010
- ...Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical C ...lar Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups:50 KB (7,152 words) - 09:23, 6 January 2012
- * Vascular disease, Age 65-74 years, Sex category (female=1)32 KB (4,336 words) - 20:38, 2 February 2015
- ...actors such as [[diabetic neuropathy|diabetic neuropathies]]; [[peripheral vascular disease]]s; and infection. With the loss of sensation and poor circulation, injurie16 KB (2,185 words) - 02:38, 21 February 2013
- ...ence of diabetes in persons at high risk"<br/>• Did not reduce [[vascular disease]] ...]] 25 - 40||[[Acarbose]] 100 mg of acarbose 3 times a day ||[[Placebo]]||[[Vascular disease]] events||"This study suggests that treating IGT patients with acarbose is98 KB (13,470 words) - 13:28, 10 February 2023
- ...lenged. JR Speakman, in a review for the International Society of Diabetes Vascular Disease, suggested that not enough significant famines have occurred in human popul21 KB (3,145 words) - 15:26, 25 February 2023
- ...e as long as the patient is otherwise healthy, shows no signs of end-organ vascular disease, and does not smoke. If blood pressure remains well controlled several mont46 KB (7,085 words) - 08:52, 26 July 2023
- ...nsin and aldosterone system in pathogenesis and management of hypertensive vascular disease. | journal=Am J Med | year= 1972 | volume= 52 | issue= 5 | pages= 633-52 |56 KB (7,418 words) - 15:13, 5 November 2013
- ...o may be improved if patients are taking low dose [[aspirin]] to prevent [[vascular disease]].<ref name="pmid21139112">{{cite journal| author=Brenner H, Tao S, Haug U|31 KB (4,194 words) - 13:28, 10 February 2023